Tag: eagle pharmaceuticals

October 30, 2018

Eagle Pharmaceuticals Announces Fulvestrant Study Results

Eagle Pharmaceuticals (Nasdaq: EGRX) announced that the Company’s fulvestrant formulation has not met the primary bioequivalence endpoints evaluating Eagle’s formulation...
July 3, 2018

Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA

Eagle Pharmaceuticals (Nasdaq:EGRX) announced that an additional patent has been issued related to BENDEKA by the United States Patent and Trademark...